Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Topical Solution for the Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 topical solution for atopic dermatitis has completed its clinical trial. The sponsor is Spherium Biomed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical solution for atopic dermatitis (unspecified)

Snippet

Sponsor: Spherium Biomed | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED